26 November

“How Science Becomes Business” – Pure Biologics e-conference for investors

Find out more about the science behind our ideas and how we turn it into value.

During the event:

  • we will tell you about our innovations,
  • we will present aptamer projects, including targeted chemotherapy with aptamers,
  • we will explain how our binding molecules are generated and validated: antibodies and aptamers,
  • we will show the key milestones and their impact on the value of projects…
  • and we will answer all your questions.


  • Dr. Filip Jeleń, Co-founder, President of the Board
  • Dr. Pieter Spee, Chief Scientific Officer
  • Dr. Ewelina Świderek, Head of the Aptamer Portfolio
  • Dr. Tomasz Klaus, Research Group Leader – Antibodies
  • Dr. Agnieszka Sok-Grochowska, Research Group Leader – Aptamers

📅 14 December 2021, Tuesday
🕚 11:00

Watch it: 🎥 Jak nauka staje się biznesem? Konferencja Pure Biologics dla inwestorów (🇵🇱)


Menu Close

We use cookies to give you the best browsing experience, site traffic analysis, and advertisement management.

Pure Biologics - Harnessing the power of antibodies and aptamers